Injectable Wegovy sales are plateauing, with growth shifting to the new oral semaglutide pill
Common: Nausea, vomiting, diarrhea, or constipation Reduced appetite (sometimes too much) Mild low blood sugar (especially with other diabetes medications) Injection site reactions Less common but serious: Pancreatitis Gallbladder issues Kidney complications from dehydration Thyroid tumors (observed in rodent studies and still under investigation in humans) This is a non-exhaustive list
This gut-first approach makes it appealing to those who want a sustainable, non-invasive alternative to prescription medications
Postmarket safety profile of suicide/self-injury for GLP-1 receptor agonist: a real-world pharmacovigilance analysis Published online by Cambridge University Press: 30 November 2023 Abstract Recent reports of individuals experiencing suicidal and/or self-injurious behaviors while using liraglutide and semaglutide have heightened the concerns regarding neuropsychiatric safety of Glucagon-like peptide-1 agonists (GLP-1RAs)
What if I can only find 1mL syringes
Clinical evidence shows no significant difference in weight loss or blood sugar control between morning and evening injections when dosed consistently
